Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (12): 767-768.
TIAN Ying, HU Guangxu*
Received:
2019-01-18
Revised:
2019-01-18
Online:
2018-12-20
Published:
2019-01-18
CLC Number:
TIAN Ying, HU Guangxu. One Case of Anaphylactic Shock Induced by Ornithine Aspartate for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(12): 767-768.
[1] 吕小丹,张婷. 注射用门冬氨酸鸟氨酸致药品不良反应23例分析[J]. 山东医药,2014,54(45):93-94. [2] 包雪青,王丽娟. 输注门冬氨酸鸟氨酸致呕吐反应 30 例分析[J]. 海峡药学,2011,23(4):216-217. [3] 朱珊梅,吴玉姣. 注射用门冬氨酸鸟氨酸致新的不良反应2例[J]. 中国药物警戒,2013,10(12):768. [4] 郭玉贤,聂文佳,魏从真.门冬氨酸鸟氨酸注射液致药物热 1 例[J]. 中国实用医药,2013,8(29):171-172. [5] 王旷靖,宋汉明.L-鸟氨酸-L-门冬氨酸治疗肝硬化肝性脑病的Meta分析[J].中国全科医学,2012,15(10C):3451-3459. [6] Han Y,You H Y,Jiang F Z.Clinical study of L-Ornithine-L-Aspartate for injection on alleviating dysfunction of liver after hepatectomy[J].Journal of Hepatopancreatobiliary Surgery,2005,17(1): 8-13. [7] 万运方,王红玲.门冬氨酸鸟氨酸联合纳洛酮治疗急性肝性脑病的临床疗效[J].武汉大学学报(医学版),2015,36(1):129-131. [8] 周泽文, 钟晓妮, 周宝勇, 等. 门冬氨酸鸟氨酸联合纳洛酮对肝性脑病患者认知功能和预后及其神经肽类水平的影响[J]. 中华肝脏病杂志,2013,21( 5 ): 385-388. [9] 刘艳秋,王丽,古曦.注射用复方三维B(II)致过敏性休克1例[J]. 中国药物警戒,2017,14(9):567-568. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||